Stay updated on Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial
Sign up to get notified when there's something new on the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page.

Latest updates to the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference2%
- Check17 days agoChange Detected- Version updated from v3.0.2 to v3.1.0. This is a metadata/versioning change with no accompanying content updates.SummaryDifference0.1%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; the 'Back to Top' link was removed, indicating a minor UI cleanup and no substantive content changes.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has added significant content related to colorectal cancer, including a new facility name, location details, and a list of relevant publications from PubMed. Additionally, it has introduced new related topics and updated the version number of the page.SummaryDifference5%
- Check60 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
Stay in the know with updates to Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page.